Research Options:
Week of Expected Pricing Pending
Company Name Biocept. Inc.
Proposed Ticker BIOC
CUSIP N/A
Business Description A cancer diagnostics company that develops and commercializes proprietary circulating tumor cell, or CTC, and circulating tumor DNA, or ctDNA, tests utilizing a sandard blood sample.
Lead Underwriter Aegis Capital Corp.
Co-Managers N/A
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.